Flagship explainer
What drives Tandem Diabetes Care, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$205M | FY2025 |
| |
| Income before tax | −$200M | FY2025 |
|
| Operating income | −$187M | FY2025 |
|
| $1.0B | FY2025 |
| |
| Ending assets | $881M | FY2025 |
|
| Beginning assets | $968M | FY2024 |
|
| $155M | FY2025 |
| |
| $263M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001438133-26-000010